World News

Pak Skips SCO Military Medicine Meet In New Delhi

New Delhi: Pakistan has abstained itself from the SCO’s Navy Medication Convention that kicked off right here on Thursday at the same time as it’s collaborating together with India in a joint anti-terror drill that’s at current underway in Russia.

The convention on army medication is the primary army co-operation occasion beneath the Shanghai Co-operation Organisation (SCO) to be organised in India after it joined the organisation in 2017.

Defence Ministry sources mentioned no official cause has been given by Pakistan for skipping the convention in New Delhi.

“An invitation was sent to Pakistan as well as all other countries of the SCO. Pakistan never responded to this invitation,” a senior ministry official advised IANS.

Pakistan has skipped the convention at the same time as it’s collaborating in a joint anti-terror army drill beneath the SCO that’s concurrently underway in Russia’s Orenburg. The 15-day-long army train started earlier this week.

Aside from India and Pakistan and host nation Russia, China and 4 Central Asian nations of Kazakhstan, Kyrgyzstan, Uzbekistan and Tajikistan – that additionally comprise the SCO – are additionally collaborating within the annual army coaching train.

The 2-day army medication convention in New Delhi is being held in accordance with the SCO Defence Co-operation Plan 2019-20. Aside from the SCO nations save Pakistan, Sri Lanka and Nepal are collaborating as dialogue companions.

Defence Minister Rajnath Singh inaugurated the convention earlier on Thursday the place he burdened upon the necessity for armed forces to develop capabilities towards the specter of bio-terror.

“I would like to underline the importance of building capabilities to deal with the menace of bio-terrorism. Bio-terror is a real threat today. It breaks out as a contagious plague and the armed forces and its medical services have to be at the forefront of combating this menace,” he mentioned.

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker